- Home
- TNGX vs CLPT Comparison
TNGX vs CLPT Comparison
Compare TNGX & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- CLPT
- Stock Information
- Founded
- TNGX 2014
- CLPT 1998
- Country
- TNGX United States
- CLPT United States
- Employees
- TNGX N/A
- CLPT N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- TNGX Health Care
- CLPT Health Care
- Exchange
- TNGX Nasdaq
- CLPT Nasdaq
- Market Cap
- TNGX 317.4M
- CLPT 370.5M
- IPO Year
- TNGX N/A
- CLPT N/A
- Fundamental
- Price
- TNGX $1.37
- CLPT $11.87
- Analyst Decision
- TNGX Strong Buy
- CLPT Strong Buy
- Analyst Count
- TNGX 7
- CLPT 2
- Target Price
- TNGX $12.33
- CLPT $25.00
- AVG Volume (30 Days)
- TNGX 789.1K
- CLPT 229.6K
- Earning Date
- TNGX 05-07-2025
- CLPT 05-06-2025
- Dividend Yield
- TNGX N/A
- CLPT N/A
- EPS Growth
- TNGX N/A
- CLPT N/A
- EPS
- TNGX N/A
- CLPT N/A
- Revenue
- TNGX $42,069,000.00
- CLPT $31,390,000.00
- Revenue This Year
- TNGX N/A
- CLPT $24.28
- Revenue Next Year
- TNGX N/A
- CLPT $42.11
- P/E Ratio
- TNGX N/A
- CLPT N/A
- Revenue Growth
- TNGX 15.17
- CLPT 31.04
- 52 Week Low
- TNGX $1.33
- CLPT $5.11
- 52 Week High
- TNGX $12.02
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- TNGX 26.22
- CLPT 34.87
- Support Level
- TNGX $1.48
- CLPT $13.09
- Resistance Level
- TNGX $1.66
- CLPT $14.01
- Average True Range (ATR)
- TNGX 0.16
- CLPT 0.65
- MACD
- TNGX -0.01
- CLPT -0.01
- Stochastic Oscillator
- TNGX 5.63
- CLPT 24.30
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.